Jusril, Hafizah
Unknown Affiliation

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

SARS-CoV-2 Antibody Seroprevalence in Jakarta, Indonesia Ariawan, Iwan; Jusril, Hafizah; N Farid, Muhammad; Riono, Pandu; Wahyuningsih, Wiji; Widyastuti, Widyastuti; Handayani, Dwi Oktavia T L; Wahyuningsih, Endang Sri; Daulay, Rebekka; Henderiawati, Retno; Malik, Safarina G; Noviyanti, Rintis; Trianty, Leily; Fadila, Nadia; Myint, Khin Saw Aye; Yudhaputri, Frilasita A.; Venkateswaran, Neeraja; Venkateswaran, Kodumudi; Udhayakumar, Venkatachalam; Hawley, William A.; Morgan, Juliette; Pronyk, Paul M
Kesmas Vol. 17, No. 3
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

The SARS-CoV-2 transmission dynamics in low- and middle-income countries remain poorly understood. This study aimed to estimate the SARS-CoV-2 antibodies seroprevalence in Jakarta, Indonesia, and to increase knowledge of SARS-CoV-2 transmission in urban settings. A population-based serosurvey among individuals aged one year or older was conducted in Jakarta. Employing a multistage sampling design, samples were stratified by district, slum, and non-slum residency, sex, and age group. Blood samples were tested for IgG against three different SARS-CoV-2 antigens. Seroprevalence was estimated after applying sample weights and adjusting for cluster characteristics. In March 2021, this study collected 4,919 respondents. The weighted estimate of seroprevalence was 44.5% (95% CI = 42.5-46.5). Seroprevalence was highest among adults aged 30-49 years, with higher seroprevalence in women and the overweight/obese group. Respondents residing in slum areas were 1.3-fold more likely to be seropositive than non-slum residents. It was estimated that4,717,000 of Jakarta's 10.6 million residents had prior SARS-CoV-2 infection. This suggests that approximately 10 infections were undiagnosed/underreported for every reported case. About one year after the first COVID-19 case was confirmed, close to half of Jakarta's residents have been infected by SARS-CoV-2.
Intervention Levers for Stunting Reduction in Indonesia: Evidence from the 2023 Indonesian Health Survey Data Ariawan, Iwan; Jusril, Hafizah; Afifa, Zahra Izza; Fitri, Azka; Utami, Elmarizha Sekar; Hasan, Mikail; Puspasari, Dwi
Kesmas Vol. 21, No. 2
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Stunting remains the largest public health challenge among macro-nutrition problems in Indonesia, affecting almost a quarter of children under five in 2023. The prevalence is considered high according to the World Health Organization standard. This study analyzed 15 aggregated provincial variables from the 2023 Indonesian Health Survey using Structural Equation Modeling (SEM), focusing on determinants of stunting among children under two to identify primary intervention levers. Findings indicated that intervention urgency should focus on the first 1,000 days, particularly the steep increase in stunting prevalence observed in the 12–24-month age range. While the highest prevalence is in Eastern provinces (e.g., Central Papua, 39.4%), 51% of children with stunting were concentrated in five densely populated provinces (e.g., West and Central Java). The SEM consistently identified underweight (standardized coefficient: 0.69) and wasting (standardized coefficient: 0.57) as the strongest positive determinants of provincial stunting prevalence. Controlling acute malnutrition is essential; a 1% decrease in wasting is projected to reduce stunting prevalence by 1.2%. Furthermore, increasing coverage of key interventions, such as complete basic immunization and appropriate complementary feeding, is negatively associated with stunting, providing critical operational targets.